ANGIOGENIC CELLS FROM HUMAN PLACENTAL PERFUSATE
First Claim
Patent Images
1. A method of forming vessels from a population of placental perfusate cells, comprising contacting said population of cells with conditions that promote the formation of vessels.
4 Assignments
0 Petitions
Accused Products
Abstract
Provided herein are the production of vasculogenic or angiogenic cells from placental perfusate. Also provided are methods of treating an individual having a cardiac or vascular insufficiency, disease, disorder or condition comprising administering to said individual placental perfusate, placental perfusate cells, or combinations of placental perfusate or perfusate cells with placental or non-placental hematopoietic stem cells or adherent placental stem cells.
-
Citations
27 Claims
- 1. A method of forming vessels from a population of placental perfusate cells, comprising contacting said population of cells with conditions that promote the formation of vessels.
- 15. A method of treating an individual having a cardiac or vascular disease, disorder, condition or insufficiency, comprising administering human placental perfusate or human placental perfusate cells to said individual in an amount sufficient to treat said disease, disorder, condition or insufficiency.
Specification